Scarica l'app Stockscreener
10.29
0.39%
0.04
Dopo l'orario di chiusura:
10.29
Precedente Chiudi:
$10.25
Aprire:
$10.2
Volume 24 ore:
1,190
Relative Volume:
0.05
Capitalizzazione di mercato:
$221.21M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.98%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$10.20
$10.29
Intervallo di 1 settimana:
$10.15
$10.29
Portata 52W:
$10.13
$10.35
Helix Acquisition Corp Iii Stock (HLXC) Company Profile
Nome
Helix Acquisition Corp Iii
Settore
Industria
Telefono
-
Indirizzo
-
Compare HLXC vs CCXI, LION, INFQ, XXI, APAD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HLXC
Helix Acquisition Corp Iii
|
10.29 | 220.35M | 0 | 0 | 0 | 0.00 |
|
CCXI
Churchill Capital Corp Xi
|
10.19 | 3.64B | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
8.50 | 2.51B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
INFQ
Infleqtion Inc
|
13.29 | 2.37B | 0 | 0 | 0 | 0.00 |
|
XXI
Twenty One Capital Inc
|
6.15 | 2.17B | 0 | 0 | 0 | 0.00 |
|
APAD
A Paradise Acquisition Corp
|
10.11 | 1.42B | 0 | 0 | 0 | 0.00 |
Helix Acquisition Corp Iii Borsa (HLXC) Ultime notizie
Whale Trades: Is MYPSW in a consolidation phaseJuly 2025 Setups & Reliable Intraday Trade Alerts - baoquankhu1.vn
What Wall Street predicts for Plutonian Acquisition Corp. Equity Warrant stock price2025 Sector Review & Safe Capital Growth Trade Ideas - mfd.ru
Will Anixa Biosciences Inc. stock reach all time highs in 2025Weekly Risk Report & Breakout Confirmation Trade Signals - mfd.ru
A | Is Helix Acquisition Corp. II on track to beat earningsMarket Activity Recap & Capital Efficient Trading Techniques - mfd.ru
Aug Opening: Is ONCO being accumulated by smart moneyQuarterly Earnings Report & Community Verified Swing Trade Signals - baoquankhu1.vn
Can AIFER ride the EV waveQuarterly Profit Review & Free Long-Term Investment Growth Plans - mfd.ru
Newsroom - White & Case LLP
Helix Acquisition Corp. III completes $172.5 million IPO and private placement - Investing.com Nigeria
Helix Acquisition Corp. III Completes Initial Public Offering - TradingView
Finance Watch: SPACs Attempt A Comeback As IPO Market Shows Signs Of Life - Citeline News & Insights
Does Helix Acquisition Corp. II have strong fundamentalsJuly 2025 Macro Moves & Advanced Technical Analysis Signals - mfd.ru
With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma - Institutional Investor
Helix Acquisition prices $150M initial public offering - MSN
Will Helix Acquisition Corp. II stock continue dividend increasesRate Cut & AI Forecast Swing Trade Picks - mfd.ru
Helix Acquisition Corp. III raises $172.5 million in Nasdaq IPO By Investing.com - Investing.com Nigeria
Helix Acquisition Corp III closes $172.5 million IPO By Investing.com - Investing.com South Africa
Helix Acquisition Corp. III closes $172.5 million IPO By Investing.com - Investing.com Australia
Helix Acquisition Corp. III raises $172.5 million in Nasdaq IPO - Investing.com
Helix Acquisition Corp. III closes $172.5 million IPO - Investing.com India
Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares - The Manila Times
SL Green Realty Corp. Announces Date of 2026 Annual Meeting of Stockholders - The Manila Times
Helix Acquisition Corp III closes $172.5 million IPO - Investing.com
White & Case advises Helix Acquisition Corp. III on upsized US$150 million IPO - White & Case LLP
Biotech investor Cormorant secures $150M for another SPAC deal - BioPharma Dive
Insider Buy: Does Unusual Machines Inc align with a passive investing strategyTrade Entry Report & Low Risk Investment Opportunities - baoquankhu1.vn
Helix Acquisition III Raises $150 Million, Targets Healthcare Sector - intellectia.ai
Helix Acquisition Corp. III Prices Upsized $150 Mln IPO - Nasdaq
Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering - The Manila Times
IPO NewsUS IPO Weekly Recap: Equipment rental rises while crypto company crashes in 2-IPO week - renaissancecapital.com
Day One was one of three parties interested in Mersana; Bihua Chen and Cormorant’s third SPAC - Endpoints News
HLXC IPO NewsCormorant's SPAC Helix Acquisition III files for a $125 million IPO, targeting healthcare - renaissancecapital.com
BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewswire
BridgeBio Oncology stock initiated with Outperform rating at Oppenheimer - Investing.com
After Short Stint as a Private Company, BBOT Leaves SPAC Process Ready To Execute - BioSpace
Helix Acquisition Corp. II Completes Merger with BridgeBio - The Globe and Mail
Cantor Fitzgerald initiates BridgeBio Oncology stock with Overweight rating By Investing.com - Investing.com Nigeria
BridgeBio Oncology Therapeutics (Helix Acquisition II): BBOT IPO, SPACBlank check company formed by Cormorant Asset Management targeting healthcare (completed 8/11/2025). - renaissancecapital.com
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition - GlobeNewswire
BridgeBio Oncology Lands Massive $382M SPAC Deal as Top Investors Back Cancer Drug Pipeline - Stock Titan
BBOT Appoints Industry Veteran Uneek Mehra as Chief Financial Officer - Business Wire
BridgeBio Oncology's SPAC Merger Advances: SEC Clears Path for Novel Cancer Drug Development Platform - Stock Titan
Longevity Biotech Takes Root on Nasdaq With $180M SPAC Deal - BioSpace
Big Law Firms Wary of SPAC Rebound Seek to Get Paid This Time - Bloomberg Law News
Helix BioPharma (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") Secures Pre-IND Candidates LEUMUNA(TM) and GEMCEDA(TM) in Strategic Acquisition from the Laevoroc Group - TheNewswire
Helix Acquisition Corp. II SEC 10-Q Report - TradingView
Swiss ADC Biotech Takes SPAC Track to NASDAQ - BioSpace
Bay Area VC-funded life sciences companies raised over $5 billion in 2024 - The Business Journals
Checkpoint checks out | ApexOncoClinical Trials news and analysis - Oncology Pipeline
BridgeBio spin-out in SPAC deal to target RAS and PI3Kα malignancies - The Pharma Letter
BridgeBio spinout to go public in SPAC deal with Helix Acquisition Corp. II - MSN
BridgeBio's KRAS-focused cancer spinout backs SPAC as path to Nasdaq - Fierce Biotech
Helix Acquisition Corp Iii Azioni (HLXC) Dati Finanziari
Non sono disponibili dati finanziari per Helix Acquisition Corp Iii (HLXC). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.45%
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):